COSCIENS Biopharma Inc (CSCID)

COSCIENS Biopharma Inc. is a Toronto-based life science company incorporated in 1990 and listed on OTC Markets as common stock. The company develops and commercializes products for cosmeceutical, nutraceutical, and pharmaceutical applications in the United States, Germany, the United Kingdom, and other international markets. Its operations are organized into Active Ingredient and Pharmaceutical segments. The active ingredient portfolio includes oat beta glucan, oat powder and peptides, oat oil, and avenanthramides, which are used in health, wellness, and inflammation-related applications across cosmeceutical and pharmaceutical settings. The pharmaceutical business includes Macrilen/Ghryvelin (macimorelin), an oral compound that stimulates growth hormone secretion from the pituitary gland. COSCIENS Biopharma sells through a distribution network and has license agreements with Pharmanovia, Davimed GmbH, NK MEDITECH Ltd, Agriculture Canada, the Canadian Government, and the University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and adopted its current name in August 2024.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.